MedPath

Effectiveness and safety of supplement drug (Linfadren®) in the management of patients with post-trauma/surgery persistent ankle edema: a randomized controlled trial

Not Applicable
Completed
Conditions
persistent ankle edema following trauma or surgery of ankle or distal leg
Musculoskeletal - Other muscular and skeletal disorders
Physical Medicine / Rehabilitation - Physiotherapy
Injuries and Accidents - Fractures
Surgery - Other surgery
Registration Number
ACTRN12621001040853
Lead Sponsor
niversity of L'Aquila
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion criteria were: 18 years or older, diagnosis of post-trauma/surgery persistent ankle edema with a difference greater than or equal to 20 mm between the affected ankle and the unaffected ankle as measured by figure-of-eight-20 method. Persistent edema was an edema that persisted for more than two weeks.

Exclusion Criteria

Exclusion criteria were: bilateral ankle edema; pulmonary edema; congestive heart failure; coagulation defects; any contraindications limiting clinical evaluation and therapy of the patient.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath